Loading...
Loading...
Dr Reddys Laboratories Ltd
₹1,200.00
ARIMA and XGBoost projections trained on data through 14 Aug 2026. Statistical extrapolation for academic purposes, not investment advice.
| Model | MAPE | RMSE | Skill |
|---|---|---|---|
| ARIMAorder=(0, 1, 0) | 1.14% | 20.62 | Beats random walk |
| XGBoostn_estimators=200,max_depth=3,lr=0.03,subsample=0.8 | 1.27% | 21.69 | No better than random walk |
| Target date | ARIMA | XGBoost |
|---|---|---|
| 17 Aug 2026 | ₹1,200.00+0.00% vs last close₹1,167.58 – ₹1,233.32 | ₹1,193.88-0.51% vs last close |
| 18 Aug 2026 | ₹1,200.00+0.00% vs last close₹1,154.41 – ₹1,247.40 | ₹1,190.18-0.82% vs last close |
| 19 Aug 2026 | ₹1,200.00+0.00% vs last close₹1,144.40 – ₹1,258.30 | ₹1,196.92-0.26% vs last close |
| 20 Aug 2026 | ₹1,200.00+0.00% vs last close₹1,136.03 – ₹1,267.57 | ₹1,201.36+0.11% vs last close |
| 21 Aug 2026 | ₹1,200.00+0.00% vs last close₹1,128.71 – ₹1,275.79 | ₹1,203.49+0.29% vs last close |
These are statistical extrapolations of past prices produced by ARIMA and XGBoost models, shown for academic purposes. Metrics come from a walk-forward backtest on data the models were not trained on.
MAPE is mean absolute percentage error and RMSE is root mean squared error, both lower-is-better. Direction is how often the predicted up/down move matched reality, where 50% is a coin flip. The random walk column predicts that tomorrow equals today; a model that does not beat it carries no predictive information.
Nothing here is investment advice or a recommendation to buy, sell or hold any security. Past price behaviour does not determine future returns.
Open
₹1,205.90
High
₹1,205.90
Low
₹1,192.40
Close
₹1,200.00
Volume
21,36,998
Daily Return
-0.50%
7-Day MA
₹1,187.54
20-Day MA
₹1,174.65
Volatility
22.61%
52-Week High
₹1,405.98
52-Week Low
₹1,101.00
Avg Volume
20,25,843
Recent headlines mentioning Dr Reddys Laboratories Ltd. Each link opens on the publisher's own site.
Dr. Reddy’s (NYSE: RDY) schedules analyst and investor meetings for September 2026
Stock Titan · 5d ago
A pre-approval inspection ends with USFDA observations at Dr. Reddy’s (RDY).
Stock Titan · 6d ago
A 10 a.m. ET earnings call is scheduled for October 23 at Dr. Reddy’s (RDY).
Stock Titan · 7d ago
Data source: Yahoo Finance via yfinance. Last recorded date: 14 Aug 2026. Historical data points: 22 records.